How many drugs treat Hypogonadotropic hypogonadism?

Drug Landscape tracks 5 marketed treatments for Hypogonadotropic hypogonadism (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/hypogonadotropic-hypogonadism.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Hypogonadotropic hypogonadism — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Hypogonadotropic hypogonadism (disease) competitive landscape: 5 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

5 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Hypogonadotropic hypogonadism, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Tlando	UNDECANOATE	Tolmar			2025-01-01
Aveed	TESTOSTERONE UNDECANOATE	Marius	Androgen	Androgen receptor	2014-01-01
Androgel	TESTOSTERONE	Besins Hlthcare	Androgen [EPC]	Androgen receptor	1972-01-01
Testosteron	Testosteron	Gulhane School of Medicine		Corticosteroid-binding globulin, Alpha-synuclein, Lanosterol 14-alpha demethylase
Choriogonadotropin	chorionic gonadotrophin	Ferring

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Besins Hlthcare · 1 drug in Hypogonadotropic hypogonadism
Ferring · 1 drug in Hypogonadotropic hypogonadism
Gulhane School of Medicine · 1 drug in Hypogonadotropic hypogonadism
Marius · 1 drug in Hypogonadotropic hypogonadism
Tolmar · 1 drug in Hypogonadotropic hypogonadism

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Hypogonadotropic hypogonadism:

Cite this brief

Drug Landscape (2026). Hypogonadotropic hypogonadism — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/hypogonadotropic-hypogonadism. Accessed 2026-06-10.

Hypogonadotropic hypogonadism full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing